The Clorox Company (CLX Quick QuoteCLX - Free Report) reported third-quarter fiscal 2018 results, wherein earnings from continuing operations of $1.37 per share rose 5% year over year and also beat the Zacks Consensus Estimate of $1.30.

The company expects earnings for fiscal 2018 to be in the range of $6.15-$6.30 per share compared with the previous guidance of $6.17-$6.37.

Earnings Estimate Revision: The Zacks Consensus Estimate for fiscal 2018 has witnessed a downtrend in the last seven days. However, if we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 2%.

Revenues: Clorox generated net sales of $1,517 million that grew 2.7% year over year and also came above the Zacks Consensus Estimate of $1,511 million. The top line growth was driven by gains across all its segments and 2020 Strategy.

The company anticipates sales growth of 3% for fiscal 2018.

Zacks Rank: Currently, Clorox carries a Zacks Rank #4 (Sell) which is subject to change following the earnings announcement.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Check back later for our full write up on Clorox’s earnings report!

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>